In humans, urinary NGAL increased not only in AKI, but also in chronic kidney disease (CKD) [37], and is a marker for delayed graft function following kidney transplantation [38], suggesting that the potential of urinary follistatin as a tubular injury marker is not limited to AKI. This evidence concerns the gene FST and chronic kidney disease.